Reducing tumor invasiveness by ramucirumab and TGF‐β receptor kinase inhibitor in a diffuse‐type gastric cancer patient‐derived cell model

BACKGROUND: Diffuse‐type gastric cancer (GC) is known to be more aggressive and relatively resistant to conventional chemotherapy. Hence, more optimized treatment strategy is urgently needed in diffuse‐type GC. METHODS: Using a panel of 10 GC cell lines and 3 GC patient‐derived cells (PDCs), we iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Song‐Yi, Byeon, Seonggyu, Ko, Jihoon, Hyung, Sujin, Lee, In‐Kyoung, Jeon, Noo Li, Hong, Jung Yong, Kim, Seung Tae, Park, Se Hoon, Lee, Jeeyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525100/
https://www.ncbi.nlm.nih.gov/pubmed/34542244
http://dx.doi.org/10.1002/cam4.4259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525100/
https://www.ncbi.nlm.nih.gov/pubmed/34542244
http://dx.doi.org/10.1002/cam4.4259

Ejemplares similares